Servana AB (XSAT:SERV) Cyclically Adjusted PB Ratio: (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Servana AB Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Servana AB  (XSAT:SERV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Servana AB Cyclically Adjusted PB Ratio Related Terms


Servana AB Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Servana AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Servana AB Cyclically Adjusted PB Ratio Chart

Servana AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.22 0.83 0.39 0.07 0.00

Servana AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.00 0.00 0.00 0.00

XSAT:SERV vs ISRG, BDX, MDLN: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Servana AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Servana AB Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Servana AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Servana AB's Cyclically Adjusted PB Ratio falls into.



Servana AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Servana AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Servana AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/133.5600*133.5600
=0.000

Current CPI (Mar. 2026) = 133.5600.

Servana AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.199 101.019 0.263
201609 0.140 101.138 0.185
201612 0.108 102.022 0.141
201703 0.081 102.022 0.106
201706 0.048 102.752 0.062
201709 0.025 103.279 0.032
201712 0.105 103.793 0.135
201803 0.081 103.962 0.104
201806 0.053 104.875 0.067
201809 0.032 105.679 0.040
201812 0.067 105.912 0.084
201903 0.054 105.886 0.068
201906 0.041 106.742 0.051
201909 0.028 107.214 0.035
201912 0.076 107.766 0.094
202003 0.064 106.563 0.080
202006 0.051 107.498 0.063
202009 0.039 107.635 0.048
202012 0.030 108.296 0.037
202103 0.079 108.360 0.097
202106 0.080 108.928 0.098
202109 0.056 110.338 0.068
202112 0.043 112.486 0.051
202203 0.032 114.825 0.037
202206 0.031 118.384 0.035
202209 0.022 122.296 0.024
202212 0.028 126.365 0.030
202303 0.022 127.042 0.023
202306 0.017 129.407 0.018
202309 0.012 130.224 0.012
202312 0.013 131.912 0.013
202403 0.010 132.205 0.010
202406 0.007 132.716 0.007
202409 0.005 132.304 0.005
202412 0.002 132.987 0.002
202503 0.002 132.825 0.002
202506 0.000 133.699 0.000
202509 0.000 133.480 0.000
202512 0.000 133.390 0.000
202603 0.000 133.560 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Servana AB Business Description

Address Zinkgatan 2, Lomma, SWE, 234 35
Servana AB formerly, Medimi AB is engaged in the development, production, and marketing of medication products. It offers Medimi Pro and Medimi Smart computerized pill dispensers that are used by patients, consumers, and healthcare staff to follow their drug schedule. The company focus on the following market segments namely Pharmaceutical industry, Hospital and retirement homes, Home Health Care, Pharmacy and private care, and Connected Health (Telemedicine), E-Health and Integration in Other Systems.